Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-004605
Filing Date
2025-07-16
Accepted
2025-07-16 15:21:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3096
  Complete submission text file 0001959173-25-004605.txt   4554
Mailing Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 781-419-1400
Syndax Pharmaceuticals Inc (Subject) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37708 | Film No.: 251127243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, WALTHAM MA 02451
Business Address
Metzger Michael A (Reporting) CIK: 0001507220 (see all company filings)

Type: 144